Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, CHF 0.05 per share
-
Shares outstanding
-
67,372,245
-
Total 13F shares
-
18,315,147
-
Share change
-
+602,444
-
Total reported value
-
$85,530,967
-
Price per share
-
$4.67
-
Number of holders
-
42
-
Value change
-
+$2,806,587
-
Number of buys
-
26
-
Number of sells
-
15
Institutional Holders of SOPHiA GENETICS SA - Ordinary Shares, CHF 0.05 per share (SOPH) as of Q4 2025
As of 31 Dec 2025,
SOPHiA GENETICS SA - Ordinary Shares, CHF 0.05 per share (SOPH) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,315,147 shares.
The largest 10 holders included
GENERATION INVESTMENT MANAGEMENT LLP, AKRE CAPITAL MANAGEMENT LLC, BANQUE PICTET & CIE SA, Alta Wealth Advisors LLC, PRINCIPAL FINANCIAL GROUP INC, Archon Capital Management LLC, ROYCE & ASSOCIATES LP, Bank Pictet & Cie (Europe) AG, 1492 Capital Management LLC, and EDMOND DE ROTHSCHILD HOLDING S.A..
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.